Filing Flows

Filing Flows › Fortress Biotech (FBIO) › Who owns the stock

Who owns Fortress Biotech (FBIO) stock

54 funds reported Fortress Biotech (FBIO) shares in their latest 13F filings, worth $20.5M in all. The largest holder is Vanguard Group ($4.0M). Last quarter 24 funds added to their stakes and 27 cut them.

Largest holders of FBIO (13F)Largest holders of FBIO (13F)Vanguard Group$4.0MVanguard Capital Management LLC$3.2MOpaleye Management$2.7MGSA Capital Partners LLP$1.4MMackenzie Financial$1.1MGeode Capital Management, LLC$920KBlackRock$688KTwo Sigma Investments, LP$654KBridgeway Capital Management, LLC$543KVanguard Fiduciary Trust$509K

Largest holders (13F)

FundSharesValueChangeQuarter
Vanguard Group1,100,570$4.0Mincrease2025-12-31
Vanguard Capital Management LLC1,037,203$3.2Mincrease2026-06-30
Opaleye Management890,000$2.7Mdecrease2026-06-30
GSA Capital Partners LLP458,472$1.4Mincrease2026-06-30
Mackenzie Financial528,913$1.1Mdecrease2026-09-30
Geode Capital Management, LLC300,521$920Kincrease2026-06-30
BlackRock224,782$688Kincrease2026-06-30
Two Sigma Investments, LP213,786$654Kincrease2026-06-30
Bridgeway Capital Management, LLC177,368$543Kdecrease2026-06-30
Vanguard Fiduciary Trust166,371$509Kincrease2026-06-30
HB Wealth Management, LLC116,675$357Kdecrease2026-06-30
Kestra Advisory Services, LLC116,235$356Kdecrease2026-06-30
Acadian Asset Management LLC107,303$327Kincrease2026-06-30
State Street101,601$311Kunchanged2026-06-30
Goldman Sachs Group96,358$295Knew2026-06-30

Fortress Biotech's latest quarter

Fortress Biotech, Q2 2026: revenue $18.7M (+14% year over year), operating margin -53.5%, net earnings $602K, operating cash flow −$59.3M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most FBIO stock?

By the latest 13F filings: Vanguard Group ($4.0M); Vanguard Capital Management LLC ($3.2M); Opaleye Management ($2.7M); GSA Capital Partners LLP ($1.4M); Mackenzie Financial ($1.1M).

What is the short interest in FBIO?

4,522,696 shares were sold short at the 2026-10-15 settlement, -7.66% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.